Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
about
Natural Polyphenols for Prevention and Treatment of CancerEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Cytotoxicity of dietary flavonoids on different human cancer typesXRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in MiceProstate cancer invasion and metastasis: insights from mining genomic data.Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer.Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic PotentialMechanisms by which interleukin-6 attenuates cell invasion and tumorigenesis in human bladder carcinoma cells.Molecular targets of luteolin in cancerMetallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells.Expression of prostate stem cell antigen is downregulated during flavonoid-induced cytotoxicity in prostate cancer cells.Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic markerRole of phytochemicals in the modulation of miRNA expression in cancer.BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
P2860
Q26739022-CAA4481A-9776-414B-BE73-00FAA522729AQ26827810-13C1C861-CDEF-472D-853E-7A10C634AC83Q27012643-56930BF0-F356-4A03-B6D2-28E9747682A8Q27333970-EB32E6B1-4441-4EEC-832E-60DDAB5D484EQ30656758-3B8A5BB6-C867-4E53-8440-70B030A0F7E7Q33827212-8C7B55E2-E9A5-4308-9AD9-2192C3CC2BCDQ35106686-A9007D5E-7B4F-4F81-B31C-9AD20C5F922AQ35138841-50D86826-0FFC-47BA-88FB-285C2464A202Q35758944-6E9F335A-6AE3-4799-A351-0684066CF513Q36847293-C94C094E-1B63-4198-93BF-02A306308D70Q36898645-5EFF5F13-A59D-4078-9940-651A88599468Q38365120-30B6B5EA-8B79-4ECE-B4BD-F849B24F990AQ39136085-D4DC2554-A1D9-4FB5-ABDC-881CE3A794B5Q41116482-1B0F0DE8-8307-47A0-B53B-8A0ADBE439CAQ41581779-27D65C80-A66B-4D7E-80BC-6C27A230F26BQ47984355-22F6C722-09A7-481F-A4AC-2AFE2818EB36Q48119603-293F148F-A367-48F4-A121-6819963CEE82
P2860
Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Upregulation of prostate-deriv ...... n in prostate carcinoma cells.
@en
Upregulation of prostate-deriv ...... n in prostate carcinoma cells.
@nl
type
label
Upregulation of prostate-deriv ...... n in prostate carcinoma cells.
@en
Upregulation of prostate-deriv ...... n in prostate carcinoma cells.
@nl
prefLabel
Upregulation of prostate-deriv ...... n in prostate carcinoma cells.
@en
Upregulation of prostate-deriv ...... n in prostate carcinoma cells.
@nl
P2093
P2860
P356
P1476
Upregulation of prostate-deriv ...... on in prostate carcinoma cells
@en
P2093
Ke-Hung Tsui
Li-Chuan Chung
Phei-Lang Chang
Tsui-Hsia Feng
P2860
P304
P356
10.1002/IJC.26284
P577
2011-08-30T00:00:00Z